Jefferies raised its price target on Array BioPharma (NASDAQ: ARRY) to $9.00 (from $8.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst PT Change

Pre-Open Stock Movers 05/10: (PRTO) (NVDA) (INCR) Higher; (YELP) (VSI) (FOSL) Lower (more...)May 10, 2017 9:29 AM Array Biopharma (ARRY) Misses Q3 EPS by 4cMay 10, 2017 8:02 AM Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2017May 10, 2017 8:00 AM After-Hours Stock Movers 05/09: (ESIO) (NVDA) (EA) Higher; (YELP) (FOSL) (ACIA) (PCLN) (DIS) Lower (more...)May 9, 2017 6:22 PM Array Biopharma (ARRY) Announces Positive Top-Line Results from Part 2 of the Phase 3 COLUMBUS StudyMay 9, 2017 4:01 PM Array BioPharma Announces Positive Top-Line Results from Part 2 of the Phase 3 COLUMBUS Study of Binimetinib and Encorafenib for BRAF-Mutant MelanomaMay 9, 2017 4:01 PM